Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 819149, 5 pages
http://dx.doi.org/10.1155/2015/819149
Research Article

IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients

1Laboratório de Imunomodulação e Novas Abordagens Terapêuticas (LINAT), Centro de Ciências Biológicas, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (NUPIT-SG), Universidade Federal de Pernambuco (UFPE), Avenida Prof. Moraes Rego, 1235, Cidade Universitária, 50670-901 Recife, PE, Brazil
2Hospital das Clínicas, Universidade Federal de Pernambuco (UFPE), Avenida Prof. Moraes Rego, 1235, Cidade Universitária, 50670-901 Recife, PE, Brazil

Received 11 May 2015; Revised 13 July 2015; Accepted 22 July 2015

Academic Editor: Anshu Agrawal

Copyright © 2015 Priscilla Stela Santana de Oliveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. N. Mehta, Y. Yu, R. Pinnelas et al., “Attributable risk estimate of severe psoriasis on major cardiovascular events,” The American Journal of Medicine, vol. 124, no. 8, pp. 775.e1–775.e6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. W.-Q. Li, J.-L. Han, A. T. Chan, and A. A. Qureshi, “Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women,” Annals of the Rheumatic Diseases, vol. 72, no. 7, pp. 1200–1205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Solovan, M. Marcu, and E. Chiticariu, “Life satisfaction and beliefs about self and the world in patients with psoriasis: a brief assessment,” European Journal of Dermatology, vol. 24, no. 2, pp. 242–247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Hawro, A. Zalewska, M. Hawro, A. Kaszuba, M. Krõlikowska, and M. Maurer, “Impact of psoriasis severity on family income and quality of life,” Journal of the European Academy of Dermatology and Venereology, vol. 29, no. 3, pp. 430–443, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Janowski, S. Steuden, A. Pietrzak et al., “Social support and adaptation to the disease in men and women with psoriasis,” Archives of Dermatological Research, vol. 304, no. 6, pp. 421–432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. F. O. Nestle, D. H. Kaplan, and J. Barker, “Mechanisms of disease: psoriasis,” The New England Journal of Medicine, vol. 361, no. 5, pp. 444–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. E. Gudjonsson and J. T. Elder, “Psoriasis: epidemiology,” Clinics in Dermatology, vol. 25, no. 6, pp. 535–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Martin, S. Guérard, M.-M. R. Fortin et al., “Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact,” Laboratory Investigation, vol. 92, no. 7, pp. 1058–1070, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. E. H. van den Bogaard, G. S. Tjabringa, I. Joosten et al., “Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases,” Journal of Investigative Dermatology, vol. 134, no. 3, pp. 719–727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Lew, A. M. Bowcock, and J. G. Krueger, “Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expression,” Trends in Immunology, vol. 25, no. 6, pp. 295–305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Lee, W. L. Trepicchio, J. L. Oestreicher et al., “Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgari,” The Journal of Experimental Medicine, vol. 199, no. 1, pp. 125–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” The Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. A. Martin, J. E. Towne, G. Kricorian et al., “The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings,” Journal of Investigative Dermatology, vol. 133, no. 1, pp. 17–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Batycka-Baran, J. Maj, R. Wolf, and J. C. Szepietowski, “The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis,” Journal of Immunology Research, vol. 2014, Article ID 628289, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Johnston, Y. Fritz, S. Dawes et al., “Keratinocyte overexpression of IL-17C promotes psoriasiform pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact Skin Inflammation,” The Journal of Immunology, vol. 190, pp. 2252–2262, 2013. View at Google Scholar
  16. G. Girolomoni, U. Mrowietz, and C. Paul, “Psoriasis: rationale for targeting interleukin-17,” British Journal of Dermatology, vol. 167, no. 4, pp. 717–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Boniface, E. Guignouard, N. Pedretti et al., “A role for T cell-derived interleukin 22 in psoriatic skin inflammation,” Clinical and Experimental Immunology, vol. 150, no. 3, pp. 407–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. N. L. Starodubtseva, V. V. Sobolev, A. G. Soboleva, A. A. Nikolaev, and S. A. Bruskin, “Genes expression of metalloproteinases (MMP1, MMP2, MMP9, and MMP12) associated with psoriasis,” Russian Journal of Genetics, vol. 47, no. 9, pp. 1117–1123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Sarra, R. Caruso, M. L. Cupi et al., “IL-21 promotes skin recruiment of CD4+ cells and drives IFN-y-dependent epidermal hyperplasia,” The Journal of Immunology, vol. 186, pp. 5435–5442, 2011. View at Google Scholar
  20. T. Sugawara, R. M. Gallucci, P. P. Simeonova, and M. I. Luster, “Regulation and role of interleukin 6 in wounded human epithelial keratinocytes,” Cytokine, vol. 15, no. 6, pp. 328–336, 2001. View at Publisher · View at Google Scholar
  21. S. Q. Crome, A. Y. Wang, and M. K. Levings, “Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease,” Clinical and Experimental Immunology, vol. 159, no. 2, pp. 109–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. P. C. M. Van De Kerkhof, “The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion,” British Journal of Dermatology, vol. 137, no. 4, pp. 661–662, 1997. View at Google Scholar · View at Scopus
  23. L. Naldi, “Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies,” Clinics in Dermatology, vol. 28, no. 1, pp. 67–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Caproni, E. Antiga, L. Melani, W. Volpi, E. Del Bianco, and P. Fabbri, “Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial,” Journal of Clinical Immunology, vol. 29, no. 2, pp. 210–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Suárez-Fariñas, K. Li, J. Fuentes-Duculan, K. Hayden, C. Brodmerkel, and J. G. Krueger, “Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis,” Journal of Investigative Dermatology, vol. 132, no. 11, pp. 2552–2564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Takahashi, H. Tsuji, Y. Hashimoto, A. Ishida-Yamamoto, and H. Iizuka, “Serum cytokines and growth factor levels in Japanese patients with psoriasis,” Clinical and Experimental Dermatology, vol. 35, no. 6, pp. 645–649, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Arican, M. Aral, S. Sasmaz, and P. Ciragil, “Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity,” Mediators of Inflammation, vol. 2005, no. 5, pp. 273–279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Lowes, T. Kikuchi, J. Fuentes-Duculan et al., “Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells,” Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1207–1211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Johansen, P. A. Usher, R. B. Kjellerup, D. Lundsgaard, L. Iversen, and K. Kragballe, “Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin,” British Journal of Dermatology, vol. 160, no. 2, pp. 319–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Michalak-Stoma, J. Bartosińska, M. Kowal, M. Juszkiewicz-Borowiec, A. Gerkowicz, and G. Chodorowska, “Serum levels of selected Th17 and Th22 cytokines in psoriatic patients,” Disease Markers, vol. 35, no. 6, pp. 625–631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Nakajima, K. Nakajima, M. Tarutani, R. Morishige, and S. Sano, “Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients,” Archives of Dermatological Research, vol. 303, no. 6, pp. 451–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. He, L. Jin, Z.-F. Liu et al., “Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis,” British Journal of Dermatology, vol. 167, no. 1, pp. 191–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Cordiali-Fei, L. Bianchi, C. Bonifati et al., “Immunologic biomarkers for clinical and therapeutic management of psoriasis,” Mediators of Inflammation, vol. 2014, Article ID 236060, 11 pages, 2014. View at Publisher · View at Google Scholar
  34. T. Elango, H. Dayalan, S. Subramanian, P. Gnanaraj, and H. Malligarjunan, “Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients,” Clinica Chimica Acta, vol. 413, no. 19-20, pp. 1652–1656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Saggini, S. Chimenti, and A. Chiricozzi, “IL-6 as a druggable target in psoriasis: focus on pustular variants,” Journal of Immunology Research, vol. 2014, Article ID 964069, 10 pages, 2014. View at Publisher · View at Google Scholar
  36. S. M. Sa, P. A. Valdez, J. Wu et al., “The effects of IL20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis,” The Journal of Immunology, vol. 178, pp. 2229–2240, 2007. View at Google Scholar
  37. K. Wolk, H. S. Haugen, W. Xu et al., “IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN- γ are not,” Journal of Molecular Medicine, vol. 87, no. 5, pp. 523–536, 2009. View at Publisher · View at Google Scholar · View at Scopus